Humanigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 01:20PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Good morning, and thanks for joining us at the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company this morning is Humanigen, and it's my pleasure to welcome and introduce CEO, Cameron Durrant, to tell us a little bit about the company.

Before I hand it over for the presentation, I just want to remind folks that there is a Q&A after the presentation. Feel free to submit a question by clicking the icon just to the right of the screen.

With that, Cameron, thanks for sharing some of your time with us this morning.

Cameron Durrant - Humanigen, Inc. - Chairman & CEO

Of course. Thank you, Eric. Great to see you again. Well, welcome, everyone, and thank you for attending the Humanigen presentation.

The focus of this 20-minute-or-so presentation will be our COVID Phase III progress and our commercial plan in the context of the rapidly changing treatment vaccination and competitive landscape.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot